Androl., 2009, doi: 10.1038/aja.2009.23
Hear Dans perspective on the rising popularity of GLP-1s and how logistic strategies, such as inventory management, risk mitigation, storage and distribution, as well as streamlining regulatory processes, bring another level of problem-solving to the complexities of these groundbreaking medicines in the ever-evolving pharma supply chain.
The danger is not merely theoretical, as manufacturing and distribution of unapproved new drugs of unknown quality has endangered or adversely impacted public health. In a press release shared with Rolling Stone , a spokesperson for Novo Nordisk said the company is focused on legal action to keep patients safe, as they believe generic attempts at semaglutide have created a high risk of consumer confusion and deception as well as potential safety concerns. Compounded products do not have the same safety, quality and effectiveness assurances as our FDA-approved drugs and may expose patients to health risks, the release says
The mental game matters more than people want to admit
Youre in trusted handslets get started